- Assistant Professor, Global Health
325 Ninth Avenue
Seattle, WA 98104
Select from the following:
Patricia Pavlinac, PhD, MS is an epidemiologist and Assistant Professor in the Department of Global Health at the University of Washington. Dr. Pavlinac also co-directs the Gut Health and Child Survival scientific priority area of the Global Center for Integrated Health of Women, Adolescents and Children (Global WACh). Her research aims to identify interventions to halt morbidity and mortality attributed to enteric infectious diseases in children. Dr. Pavlinac has extensive experience coordinating pediatric studies in Kenya including her current director role in two clinical trials testing whether empiric use of a broad-spectrum antibiotic improves post-acute survival and growth in Kenyan children. These trials build on evidence that Kenyan children suffer an elevated risk of mortality and chronic malnutrition after acute infectious illnesses that may be due to inadequately treated or new exposure to bacterial pathogens.
- MS (University of Washington)
- BA (Colgate University)
- PhD (University of Washington)
- Child Mortality
- Diarrheal Diseases
- Antibiotics for Children with Severe Diarrhea (ABCD Trial)
- Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children (Toto Bora Trial)
- Modulation of EPEC susceptibility and severity by an HIV- or antibiotic- altered intestinal microbiome.
- Optimal use of antibiotics in young children at high risk of diarrhea associated mortality.
- The Epidemiology of Extended Spectrum Beta Lactamase and Macrolide Resistance Genes in Kenyan Children Discharged from Hospital
Walson JL, Pavlinac PB. Targeting enteric pathogens to improve childhood survival and growth. Lancet Glob Health. 2018 Dec;6(12):e1258-e1259.
Tickell KD, Brander RL, Atlas HE, Pernica JM, Walson JL, Pavlinac PB. Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis. Lancet Global Health 2017; 5: e1235-e1248; PMC5695759
Pavlinac PB, Singa BO, John-Stewart GC, Richardson BA, Brander RL, McGrath CJ, Tickell KD, Amondi M, Rwigi D, Babigumira JB, Kariuki S, Nduati R, Walson JL. Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial). BMJ Open 2017; 7: e019170; PMC5778294
Brander RL, Walson JL, John-Stewart GC, Naulikha JM, Ndonye J, Kipkemoi N, Rwigi D, Singa BO, Pavlinac PB. Correlates of multi-drug non-susceptibility in enteric bacteria isolated from Kenyan children with acute diarrhea. PLoS Neglected Tropical Diseases 2017; 11: e0005974; PMC5638605